Speakers

Pierre Boulas

Head of Medical Devices and Packaging Development • Biogen

Dr. Pierre Boulas is Vice President, Head of Medical Device and Packaging Development at Biogen. His team is responsible for all aspects of devices and packaging development across the Biogen pipeline (small molecules, oligonucleotides, biologics and gene therapy). It provides end-to-end support through the design, development, clinical and commercial-scale production of innovative patient-centric product presentations for people living with serious neurological and neurodegenerative diseases. For the past 25 years, Dr. Boulas has been involved in all aspects of CMC technical support of pharmaceutical development programs for a variety of therapies and modalities. His main interests are in fostering change and innovation in pharmaceutical operations and incorporating patients’ insights in drug development strategies. Dr. Boulas is a strong proponent of pre-competitive collaboration to accelerate innovation in the pharmaceutical industry. From 2012 to 2021, he played various leadership roles in the IQ Consortium including Chair of the Board in 2017 and 2018. The IQ Consortium is a technically-focused organization of 40+ pharmaceutical and biotechnology companies with a mission of advancing science-based and scientifically-driven standards and regulations for pharmaceutical and biotechnology products worldwide. Dr. Boulas received a PhD in Analytical Chemistry from the University of Houston, Texas and a graduate degree from the Engineering School of Physics and Chemistry of Bordeaux, France.

Also Speaking

Aditi Singh

Global Senior Marketing Manager  • Sony Biotechnology Inc

Xavier De Mollerat Du Jeu

Senior Director of Research and Development • Thermo Fisher Scientific Inc

Jennifer Chow

Chief Executive Officer & Managing Director • Chimeric Therapeutics

Also Speaking

Image

Post-Event Report

Download the post-event report for Advanced Therapies Week 2024.
Image

Investor List

Take a look at some of the investors who attended Advanced Therapies Week 2023.